All-in-one platform
same RNA-LNP
at every scale
Accelerate and secure your RNA-LNP development with an intuitive and built to scale instrument.
One platform from screening to continuous manufacturing
High-quality RNA-LNPs from 250 µL to Liters
Identical CQAs at every scale: comparability by design
Already adopted by leading research institutions worldwide

What makes SERENA® unique?
Powered by NanoPulse®, our proprietary mixing technology, SERENA® makes identical RNA-LNPs from µL to manufacturing scale, on one platform.
One instrument, screening to production
From 250 µL screening batches, with minimal losses, to clog-free continuous production at 50 L/h (post-dilution), with the same settings.
On unified platform to make your development easier.
Comparability by design
Identical mixing process at every scale, so equivalence is built in, not proven after each change.
No re-engineering, no re-validation, for faster development and de-risked path to the clinic.
Tune characteristics, keep your flow
Keep TFR & FRR stable from small to large batches.
Tune CQAs (size, morphology, …) using frequency only, for maximum control over your LNP with no impact on throughput.
Take the tech transfer out of scale-up
Changing technology mid-scale-up means costly tech transfer, delays and added risk.
With SERENA®, only the volume changes — same platform, same process, same RNA-LNP.
Proof at every scale
Same RNA-LNP size, PDI and encapsulation with SERENA®, from 0.25 mL to over 4 L of continuous production.
Quality from low volume, kept at scale
High-quality RNA-LNPs from 250 µL, with minimal losses, and their characteristics remain consistent as you scale up.
Consistent, clog-free continuous production
RNA-LNP CQAs remain consistent throughout continuous production, without clogging or fouling.
Control characteristics without touching your flow
Tune RNA-LNP characteristics with injection frequency alone, while TFR and FRR stay fixed.
Discuss your scale-up
Tell us where your RNA-LNP program stands today and the scale you are aiming for. Our formulation experts will get back to you within 24 hours.
Screening → Optimization → Manufacturing.
Same RNA-LNP at every step.

NanoPulse® technology
Every pulse, the same mix, any scale
In an RNA-LNP, the process is part of the product — any change to the mixing changes your RNA-LNP.
NanoPulse® mixes in high-frequency pulses, and each pulse mixes the same way at any scales: the RNA-LNP you validate is the one you manufacture.
Efficient mixing. Each pulse’s parabolic flow profile drives fast, efficient mixing.
Consistent mixing. Every pulse sees the same conditions: the same particle at every scale.
Self-cleaning by design. Pulsatile flow prevents build-up on channel walls: no fouling, even in long continuous runs.
Same conditions, same nanoparticles: reproducibility that doesn’t depend on batch size.
Using SERENA®
Need more volume? Run longer.
Same parameters, same RNA-LNPs.
Easy to use. Set the frequency, TFR, FRR and volume, load your aqueous and organic phases, and run.
Built-in sequencer. Program a series of runs, such as triplicates or a parameter screen, and SERENA® runs them automatically, so quick screening becomes effortless.
Automated cleaning. An integrated cleaning protocol readies SERENA® for the next run and minimizes cross-contamination.
In-line dilution. Integrated dilution, up to 1:10, built into the run.
Your path to GMP
Develop and scale on SERENA® today. Move to the GMP version when your program is ready.
Same NanoPulse® mixer, built with GMP-compatible materials: direct transfer, same RNA-LNP
SERENA® GMP
Version coming soon
Identical mixer for direct transfer from RUO to GMP
GMP compliant, including 21 CFR Part 11
Availability: contact us
With you at every step
From your first question to daily use. And beyond, whenever you need us.
Discovery
See how SERENA® fits your process: no commitment
Proof of concept study on your RNA-LNP
Talk to our LNP specialists about your scale-up
Demo options
Installation
We get you up and running
Setup and onboarding to get you started quickly
IQ/OQ installation
RNA-LNP training program: from theory to advanced practice
Long-term support
A real partnership doesn’t stop at delivery
Clearly defined warranty and maintenance terms
Dedicated technical support
Maintenance and warranty extension plans
SERENA® specifications
Key specs at a glance.
| Specification | SERENA® (research use only) |
|---|---|
| Volume range | 250 µL to continuous production Large-scale add-on required above 30 mL |
| Throughput / TFR | Up to 50 L/h, or ~830 mL/min (post-dilution) 4.5 L/h, or 75 mL/min (pre-dilution) |
| FRR range | 1:1 to 1:10 |
| Dilution ratio | 0 to 1:10 |
| Mixing technology | NanoPulse® active mixing, identical at every scale |
| Particle tuning parameters | Injection frequency, total flow rate (TFR) and flow rate ratio (FRR), each set independently |
| Operating modes | Single run: one batch, from 250 µL Sequence: automated series of runs, such as triplicates or parameter screens Continuous: uninterrupted, clog-free production (with the large-scale add-on) |
| Status | Research use only (RUO). GMP version available soon |
Ready to discuss your scale-up?
Talk to one of our formulation experts about taking your RNA-LNP from screening to manufacturing.
Response within 24 hours. Your data is secure & never shared
SERENA® resources
Frequently asked questions about SERENA®
SERENA® is currently available for research use only (RUO), built on a GMP-ready design. A GMP version is in development, using the same NanoPulse® mixing mechanism, so a process developed on SERENA® today is designed to transfer to clinical manufacturing without a change of technology.
SERENA® covers from 250 µL up to continuous production at 50 L/h of RNA-LNP (post-dilution). Because SERENA® scales by run time rather than by mixer geometry, the mixing conditions stay the same across the whole range.
TAMARA is our microfluidic system for R&D: precise formulation from 200 µL to 30 mL, ideal for screening and preclinical work. SERENA® delivers the same RNA-LNP quality and adds scale-up, from 250 µL to continuous production at 50 L/h (post-dilution), with identical mixing at every scale. Built for teams that need their RNA-LNP to translate to the clinic.
Yes. Formulations developed by pipette mixing, home-made syringe-pump setups, microfluidics or other methods can be transferred to SERENA®. Because NanoPulse® is a different mixing mechanism, expect a one-time adjustment of injection frequency and flow parameters to match your reference CQAs. Once matched on SERENA®, no further re-optimization is needed as you scale.
SERENA® will be available from Q1 2027.
